Lilly is opening up its proprietary AI models to biotech companies that want to use them to jumpstart their science.

The 2025 Bioprocessing Summit revealed knowledge gaps and changing mindsets. As some companies look towards the future, ...

NEW HAVEN, CT / ACCESS Newswire / September 4, 2025 / Revalia Bio Inc., announced a 14.5M seed funding round to support their ...

In June, Google DeepMind took the wraps off AlphaGenome, its latest machine learning model for biological discovery. While ...

A global research consortium of over 100 study groups in more than 65 countries has launched the Global RETFound initiative, ...

NEW YORK, NY / ACCESS Newswire / September 4, 2025 / Digital Power Optimization, Inc. (“DPO”), a developer at the ...

LCGC International spoke to Dave Abramowitz, unified product management and product ownership team for chromatography and ...

The team behind Vercel’s V0, an AI-powered platform for web creation, has developed an AI model it claims excels at certain website development tasks. Available through an API, the model, called “v0-1 ...

A new kind of large language model, developed by researchers at the Allen Institute for AI (Ai2), makes it possible to control how training data is used even after a model has been built.